Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (not Standard BioTools Inc.) on August 1, 2019. The filing serves to report the company's financial results for the second fiscal quarter of 2019 via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the 8-K filing and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no specific financial metrics are available in this text.
Material Changes
The filing text does not provide specific figures or descriptions of material changes compared to the prior comparable period. It only indicates that results for the second fiscal quarter of 2019 were reported.
Guidance, Outlook, and Risks
The text contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It strictly notes that the information is "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the correct registrant name: The filing is for Fluidigm Corporation, not Standard BioTools Inc.
- Review Exhibit 99.1 (the press release) to obtain actual revenue, net income, and cash flow figures for Q2 2019.
- Confirm the trading symbol FLDM on the Nasdaq Global Select Market.
- Note that the financial data in this specific 8-K text is not incorporated by reference into future filings unless expressly stated.